This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2018-2025.
Company Filing History:
Years Active: 2018-2025
Title: Werner Schmidt: Innovator in Ocular Treatments
Introduction
Werner Schmidt is a notable inventor based in Fort Worth, TX (US), recognized for his contributions to the field of ocular treatments. With a total of 3 patents, he has made significant strides in addressing age-related eye disorders.
Latest Patents
Among his latest patents, Schmidt has developed methods for treating age-related macular degeneration. This innovative method aims to reduce the treatment burden for patients suffering from intraocular neovascular disorders. It involves administering a therapeutically effective amount of VEGF antagonist on a dosing schedule that includes treatment intervals of 8 and/or 12 weeks. Additionally, he has patented methods for treating ocular diseases with brolucizumab, which follows a similar approach to reduce the treatment burden for affected patients.
Career Highlights
Throughout his career, Schmidt has worked with prominent companies such as Novartis AG and Novartis Pharma AG. His experience in these organizations has contributed to his expertise in developing effective treatments for ocular diseases.
Collaborations
Some of his notable coworkers include Margarita Gekkieva and Andreas Weichselberger, who have collaborated with him on various projects in the field of ocular research.
Conclusion
Werner Schmidt's innovative work in ocular treatments has made a significant impact on the medical field, particularly in addressing age-related eye disorders. His patents reflect a commitment to improving patient care and reducing treatment burdens.